×
For best experience we recommend to activate Javascript in your browser.
Recombinant UBE2I antibody (Biotin)
The Rabbit Monoclonal anti-UBE2I antibody has been validated for WB, IHC, IF, ICC, IP and FACS. It is suitable to detect UBE2I in samples from Human, Mouse and Rat.
Quick Overview for Recombinant UBE2I antibody (Biotin) (ABIN7783314)
Target
See all UBE2I Antibodies
UBE2I
(Ubiquitin-Conjugating Enzyme E2I (UBE2I))
Antibody Type
Recombinant Antibody
Reactivity
All reactivities for UBE2I antibodies
Human, Mouse, Rat
Host
All hosts for UBE2I antibodies
Rabbit
Clonality
All clonalities for UBE2I antibodies
Monoclonal
Conjugate
All conjugates for UBE2I antibodies
This UBE2I antibody is conjugated to Biotin
Application
All applications for UBE2I antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC), Immunoprecipitation (IP), Flow Cytometry (FACS)
Product Details anti-UBE2I Antibody (Biotin)
(hide)
Purpose
Conjugated UBE2I Rabbit mAb
Specificity
UBE2I Antibodydetects endogenous levels of total UBE2I
Purification
Affinity-chromatography
Immunogen
A synthesized peptide derived from human UBE2I
Alternatives
(show)
Application Details
(hide)
Application Notes
working with enzyme-conjugated streptavidin, most applications: 1: 50 - 1: 1,000
Restrictions
For Research Use only
Handling
(hide)
Buffer
Liquid in PBS, 0.5 % BSA, 40 % Glycerol, 0.02 % Sodium Azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Protect from light!
Storage
4 °C
Storage Comment
Store at 4°C in dark for 6 months
Target Details for UBE2I
(hide)
Target
UBE2I
(Ubiquitin-Conjugating Enzyme E2I (UBE2I))
Alternative Name
UBE2I
Background
C358B7.1, P18, UBC9, UBE2I, SUMO1 protein ligase,
UniProt
P63279
Pathways
Intracellular Steroid Hormone Receptor Signaling Pathway , Regulation of Intracellular Steroid Hormone Receptor Signaling , Ubiquitin Proteasome Pathway
Recently viewed
(hide)
Chat with us , powered by LiveChat